Search results
US FDA approves Roche's drug for a chronic blood disorder
Reuters· 3 days ago, opens new tab drug for a chronic blood disorder, the Swiss drugmaker said. The drug crovalimab,...
AstraZeneca's (AZN) Truqap Gets EU Nod for Breast Cancer
Zacks· 5 days agoFree Report) announced that the European Commission (EC) has approved Truqap (capivasertib) in combination with Faslodex (fulvestrant) for a breast cancer indication. The EC has approved Truqap ...
Admiral Group And Two Other UK Exchange Stocks Estimated As Undervalued For Investment Consideration
Simply Wall St. via Yahoo Finance· 6 days agoThe United Kingdom's financial markets are currently poised at a critical juncture, with the FTSE...
Pharma Stock Roundup: FDA Nod to MRK's New Jab & Expanded Use of ABBV & AZN Drugs
Zacks via Yahoo Finance· 4 days agoFDA approves Merck's (MRK) 21-valent pneumococcal conjugate vaccine, Capvaxive and the expanded use...
US Supreme Court gives pharma companies a chance to thwart terrorism-funding lawsuit
WHTC 1450 Holland· 18 hours agoBy Mike Scarcella WASHINGTON (Reuters) - The U.S. Supreme Court gave boost on Monday to a challenge...
Nvidia Still One Of 24 'Perfect' Stocks — For Now Anyway
Investor's Business Daily· 13 hours ago...SMR Rating A/D Rating Argan AGX 99 7 90 97 B A Arm Holdings ARM 99 2 99 99 A A+ Broadcom AVGO 99...
Britain snubs GSK in favour of US pharma giant for RSV vaccine
The Telegraph via Yahoo News· 16 hours agoThe NHS has turned to US drugs giant Pfizer over its British rival GSK for vaccines against...
Pancreatic Cancer Market Is Projecting to Expand As NCI-Funded Research Expects to Empower Market...
Morningstar· 5 days agoFN Media Group News Commentary - The National Cancer Institute’s (NCI) funding of research projects is predicted to empower the Pancreatic Cancer Market to grow. Unlike traditional therapeutic ...
G1 Therapeutics' breast cancer drug fails in late-stage trial
Reuters via Yahoo News· 22 hours agoG1's drug trilaciclib was tested in 187 patients with metastatic triple-negative breast cancer, with the patients who took the drug showing a median overall survival of 17.4 months, while patients ...
Pharma Stock Roundup: FDA Nod to MRK's New Jab & Expanded Use of ABBV & AZN Drugs
Zacks· 4 days agoFDA approves Merck's (MRK) 21-valent pneumococcal conjugate vaccine, Capvaxive and the expanded use of AbbVie's (ABBV) Skyrizi and AstraZeneca's (AZN) Imfinzi.